I
International Clinical Research | Murfreesboro, TN
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
fezolinetant
CC-93538
Ixekizumab
Guselkumab
Dupilumab
LY3009104
Lebrikizumab
Baricitinib
PP405
Cendakimab
Parent organization
This site is a part of International Clinical Research
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 9 total trials
The main purpose of this study is to determine the efficacy and safety of baricitinib for the treatment of severe or very severe alopecia areata (hai...
Enrolling
Hair Diseases
Alopecia
Drug: Placebo
Drug: Baricitinib
Locations recently updated
The study is designed to validate efficacy and long term safety of PP405.
Enrolling
Androgenetic Alopecia
Drug: Vehicle Topical Gel
Drug: PP405 0.05% Topical Gel
Trial sponsors
S
P
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems